Therefore, despite a report that ΔNp63α can downregulate IGFBP-3 in squamous epithelial cell lines [41], this does not appear to be a likely mechanism of IGFBP-3 downregulation by DNA-damaging drugs in breast cancer cell lines. This evidence concerns the gene IGFBP3 and breast cancer.